Inpatient and Outpatient Orderable
Synonyms
|
- CERAMIDES, PLASMA
- LAB11313
|
Procedure Name
|
CERAMIDES, PLASMA
|
Procedure Master Number
|
LAB11313
|
Procedure ID
|
114982
|
Clinical Info
|
Evaluating for the risk of major adverse cardiovascular events within the next 1 to 5 years
MI-Heart Ceramides is a blood test that measures risk for adverse cardiovascular events and quantifies plasma ceramides. Plasma ceramides are predictors of adverse cardiovascular events resulting from unstable atherosclerotic plaque.
|
Specimen Sources
|
Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
|
Specimen Types
|
Blood
|
Container
|
Lavender Top Tube
|
Collection Instructions
|
Collection Container/Tube: Lavender top (EDTA)
Specimen : 1 mL EDTA Plasma (0.5 mL min)
Transport Temperature: Frozen
Collection Instructions: Freeze within 8 hours.
Patient Preparation: Patients should not be receiving Intralipid because it may cause false-elevations in measured ceramides
|
Specimen Volume
|
1 mL EDTA plasma ( 0.5 mL min)
|
Transport Instructions
|
|
Specimen Stability
|
8 Hours Room Temperature
1 Day Refrigerated
30 Days frozen
|
Methodology
|
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
|
Days Performed
|
TAT: 3-10 Days
|
Performing Laboratory
|
Mayo Clinic Laboratories
|
CPT
|
0119U
LOINC Code: 93883-7
|
PDM
|
1859767
|
Only Orderable at Locations:
|
Orderable Everywhere
|
Results
|
| Component Name |
Base Name |
Common Name |
External Name |
| CERAMIDE (16:0) |
CERAMIDE160 |
CERAMIDE 160 |
Ceramide (16:0) |
| CERAMIDE (18:0) |
CERAMIDE180 |
CERAMIDE 180 |
Ceramide (18:0) |
| CERAMIDE (24:1) |
CERAMIDE24 |
CERAM24 |
Ceramide (24:1) |
| CERAMIDE (16:)/(24:0) |
CERAMIDE1624 |
CERAMINE 16 240 |
Ceramide (16:)/(24:0) ratio |
| CERAMIDE (18:0)/(24:0) |
CERAMIDE1824 |
CERAM1824RT |
Ceramide (18:0)/(24:0) ratio |
| CERAMIDE (24:1)/(24:0) |
CERAMIDE2424 |
CERAM2424RT |
Ceramide (24:1)/(24:0) ratio |
| CERAMIDE SCORE |
CERAMIDESCO |
CERAMSC |
MI-Heart Ceramide Risk Score |
|
Result Interpretation
MI-Heart Ceramide Risk Score:
0-2 Lower risk
3-6 Moderate risk
7-9 Increased risk
10-12 Higher risk
Ceramide (16:0): 0.19-0.36 mcmol/L
Ceramide (18:0): 0.05-0.14 mcmol/L
Ceramide (24:1): 0.65-1.65 mcmol/L
Ceramide (16:0)/(24:0): <0.11
Ceramide (18:0)/(24:0): <0.05
Ceramide (24:1)/(24:0): <0.45
Reference values have not been established for patients who are
<18 years of age.
Note: Ceramide
(24:0) alone has not been independently associated with disease and
will not be reported.
|
Forms
|
|
